Schall Thomas J.
President and CEO at ChemoCentryx, Inc.
- Sold, on record
- $57.7M
- Dollars the filings state
- Form 4 sales
- 42
- Latest Aug 4, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ChemoCentryx, Inc.President and CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ChemoCentryx, Inc.Plan not statedFeb 4, 2020 2020
Sold 119,525 shares at $45.18 ($5.4M)
Schall Thomas J., President and CEO
Sold 5% of holdings ($108M position)2.3M shares left1.7x usual sizeFiling
- 2 Form 4 sale ChemoCentryx, Inc.Plan not statedFeb 20, 2020 +16 days
Sold 78,681 shares at $50.44 ($4M)
Schall Thomas J., President and CEO
Sold 3.4% of holdings ($118M position)2.3M shares left0.8x usual sizeFiling
- 3 Form 4 sale ChemoCentryx, Inc.Plan not statedMar 4, 2020 +13 days
Sold 40,844 shares at $50.35 ($2.1M)
Schall Thomas J., President and CEO
Sold 1.8% of holdings ($116M position)2.3M shares left0.5x usual sizeFiling
- 4 Form 4 sale ChemoCentryx, Inc.Plan not statedMay 5, 2020 +62 days
Sold 8,851 shares at $55.01 ($487k)
Schall Thomas J., President and CEO
Sold 0.4% of holdings ($125M position)2.3M shares left0.1x usual sizeFiling
- 5 Form 4 sale ChemoCentryx, Inc.Plan not statedMay 12, 2020 +7 days
Sold 110,674 shares at $56.22 ($6.2M)
Schall Thomas J., President and CEO
Sold 4.7% of holdings ($134M position)2.3M shares left1.4x usual sizeFiling
- 6 Form 4 sale ChemoCentryx, Inc.Plan not statedJun 15, 2020 +34 days
Sold 90,753 shares at $65.08 ($5.9M)
Schall Thomas J., President and CEO
Sold 3.8% of holdings ($154M position)2.3M shares left1.5x usual sizeFiling
- 7 Form 4 sale ChemoCentryx, Inc.Plan not statedDec 15, 2020 +183 days
Sold 28,772 shares at $65.02 ($1.9M)
Schall Thomas J., President and CEO
Sold 1.3% of holdings ($149M position)2.3M shares left0.3x usual sizeFiling
- 8 Form 4 sale ChemoCentryx, Inc.Plan not statedAug 4, 2022 +597 days
Sold 130,000 shares at $50.24 ($6.5M)
Schall Thomas J., President and CEO
Sold 5.2% of holdings ($127M position)2.4M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (42)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | Aug 8, 2022 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 130,000 | $6.5M | 5.2% | Plan not stated | SEC |
| Dec 15, 2020 | Dec 16, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 28,772 | $1.9M | 1.3% | Plan not stated | SEC |
| Jun 15, 2020 | Jun 16, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 90,753 | $5.9M | 3.8% | Plan not stated | SEC |
| May 12, 2020 | May 12, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 110,674 | $6.2M | 4.7% | Plan not stated | SEC |
| May 5, 2020 | May 7, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 8,851 | $487k | 0.4% | Plan not stated | SEC |
| Mar 4, 2020 | Mar 5, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 40,844 | $2.1M | 1.8% | Plan not stated | SEC |
| Feb 20, 2020 | Feb 21, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 78,681 | $4M | 3.4% | Plan not stated | SEC |
| Feb 4, 2020 | Feb 6, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 119,525 | $5.4M | 5.0% | Plan not stated | SEC |
| Jan 17, 2020 | Jan 17, 2020 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 136,052 | $5.6M | 5.7% | Plan not stated | SEC |
| Nov 26, 2019 | Nov 27, 2019 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 279,166 | $8.8M | 11.1% | Unusual | SEC |
| Apr 2, 2019 | Apr 2, 2019 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 160,000 | $2.2M | 6.7% | Unusual | SEC |
| Jan 10, 2019 | Jan 14, 2019 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 36,762 | $447k | 1.6% | Plan not stated | SEC |
| Jan 9, 2019 | Jan 9, 2019 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 20,170 | $242k | 0.9% | Plan not stated | SEC |
| Nov 7, 2018 | Nov 9, 2018 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 7,211 | $87k | 0.3% | Plan not stated | SEC |
| Jun 29, 2018 | Jul 2, 2018 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 10,857 | $152k | 0.5% | Plan not stated | SEC |
| May 23, 2018 | May 23, 2018 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 92,798 | $1.2M | 4.1% | Plan not stated | SEC |
| May 17, 2018 | May 17, 2018 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 200,000 | $2.4M | 8.4% | Plan not stated | SEC |
| May 2, 2018 | May 3, 2018 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 50,000 | $551k | 2.2% | Plan not stated | SEC |
| Apr 1, 2015 | Apr 1, 2015 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 24,267 | $182k | 1.1% | Plan not stated | SEC |
| Mar 25, 2015 | Mar 27, 2015 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 900 | $7k | 0.0% | Plan not stated | SEC |
| Mar 24, 2015 | Mar 24, 2015 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 50,371 | $395k | 2.3% | Plan not stated | SEC |
| Mar 19, 2015 | Mar 20, 2015 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 18,146 | $151k | 0.8% | Plan not stated | SEC |
| Mar 17, 2015 | Mar 18, 2015 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 31,316 | $268k | 1.4% | Plan not stated | SEC |
| May 1, 2014 | May 2, 2014 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 27,726 | $155k | 1.3% | Plan not stated | SEC |
| Apr 29, 2014 | Apr 30, 2014 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 32,274 | $174k | 1.5% | Unusual | SEC |
| Mar 17, 2014 | Mar 19, 2014 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 20,000 | $145k | 0.9% | Plan not stated | SEC |
| Feb 18, 2014 | Feb 20, 2014 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 20,000 | $141k | 0.9% | Plan not stated | SEC |
| Jul 16, 2013 | Jul 17, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 22,089 | $318k | 1.0% | Unusual | SEC |
| Jul 1, 2013 | Jul 3, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 311 | $5k | 0.0% | Plan not stated | SEC |
| May 15, 2013 | May 17, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 7,600 | $107k | 0.3% | Plan not stated | SEC |
| Apr 11, 2013 | Apr 12, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 2,529 | $35k | 0.1% | Plan not stated | SEC |
| Apr 2, 2013 | Apr 2, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 756 | $11k | 0.0% | Plan not stated | SEC |
| Mar 18, 2013 | Mar 19, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 16,801 | $237k | 0.8% | Plan not stated | SEC |
| Mar 14, 2013 | Mar 14, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 4,905 | $69k | 0.2% | Plan not stated | SEC |
| Mar 11, 2013 | Mar 11, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 6,948 | $97k | 0.3% | Plan not stated | SEC |
| Mar 6, 2013 | Mar 6, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 5,541 | $78k | 0.3% | Plan not stated | SEC |
| Mar 1, 2013 | Mar 1, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 15,000 | $204k | 0.7% | Plan not stated | SEC |
| Feb 22, 2013 | Feb 26, 2013 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 7,500 | $90k | 0.3% | Plan not stated | SEC |
| Nov 20, 2012 | Nov 21, 2012 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 2,100 | $25k | 0.1% | Plan not stated | SEC |
| Nov 16, 2012 | Nov 16, 2012 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 20,400 | $257k | 0.9% | Plan not stated | SEC |
| Nov 6, 2012 | Nov 8, 2012 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 22,500 | $270k | 1.0% | Plan not stated | SEC |
| Oct 1, 2012 | Oct 3, 2012 | ChemoCentryx, Inc. | President and CEO | Form 4 sale | 15,000 | $173k | 0.6% | Plan not stated | SEC |